GITTO, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 5.630
EU - Europa 3.859
AS - Asia 3.593
SA - Sud America 810
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 98
OC - Oceania 27
Totale 14.186
Nazione #
US - Stati Uniti d'America 5.476
RU - Federazione Russa 1.313
IT - Italia 1.235
SG - Singapore 957
CN - Cina 914
BR - Brasile 659
HK - Hong Kong 490
VN - Vietnam 432
PL - Polonia 337
KR - Corea 333
IE - Irlanda 281
SE - Svezia 162
FI - Finlandia 160
FR - Francia 122
BD - Bangladesh 112
IN - India 92
CA - Canada 87
DE - Germania 76
JO - Giordania 64
GB - Regno Unito 59
AR - Argentina 58
ID - Indonesia 55
NL - Olanda 29
IQ - Iraq 28
EC - Ecuador 27
JP - Giappone 27
AU - Australia 26
MX - Messico 26
PY - Paraguay 20
ZA - Sudafrica 17
CH - Svizzera 14
ES - Italia 14
UA - Ucraina 14
PK - Pakistan 13
CI - Costa d'Avorio 12
NG - Nigeria 12
UZ - Uzbekistan 11
CL - Cile 10
CO - Colombia 10
MA - Marocco 10
TR - Turchia 10
PH - Filippine 9
RO - Romania 9
VE - Venezuela 9
KE - Kenya 8
CR - Costa Rica 7
EG - Egitto 7
JM - Giamaica 7
PE - Perù 7
SA - Arabia Saudita 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
NP - Nepal 6
BJ - Benin 5
PR - Porto Rico 5
CZ - Repubblica Ceca 4
MY - Malesia 4
PT - Portogallo 4
BO - Bolivia 3
CG - Congo 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
LB - Libano 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
SV - El Salvador 3
TG - Togo 3
TN - Tunisia 3
AM - Armenia 2
AT - Austria 2
AZ - Azerbaigian 2
BB - Barbados 2
BY - Bielorussia 2
DK - Danimarca 2
LT - Lituania 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BS - Bahamas 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GN - Guinea 1
IS - Islanda 1
KG - Kirghizistan 1
Totale 14.005
Città #
Santa Clara 1.454
Ashburn 795
Singapore 744
Hong Kong 415
Fairfield 355
Warsaw 332
Seoul 330
Hefei 299
Dublin 280
Milan 236
Ho Chi Minh City 172
San Jose 170
Council Bluffs 142
Woodbridge 142
Lawrence 134
Seattle 131
Rome 121
Helsinki 119
Houston 115
Altamura 112
Cambridge 112
Florence 105
Beijing 104
Los Angeles 98
Chandler 82
Wilmington 82
Moscow 80
Hanoi 78
Lauterbourg 71
Boston 70
Princeton 67
Dallas 64
Buffalo 63
New York 62
The Dalles 62
São Paulo 55
Mumbai 53
Ann Arbor 43
Naples 43
Boardman 41
Jakarta 38
San Diego 38
Bologna 37
Kent 37
Lappeenranta 33
Shanghai 31
Munich 28
Melbourne 25
Redondo Beach 23
Tokyo 23
Toronto 22
Turin 21
Chicago 20
Da Nang 20
Figino 19
Frankfurt am Main 19
London 19
Medford 16
Norwalk 15
Denver 14
Dong Ket 14
Phoenix 14
Bengaluru 13
Genoa 13
Miano 13
Rio de Janeiro 13
Abidjan 12
Orem 12
Palermo 12
Paris 12
Porto Alegre 12
Abuja 11
Asunción 11
Bern 11
Brasília 11
Haiphong 11
Quito 11
Thái Bình 11
Brooklyn 10
San Francisco 10
West Jordan 10
Yubileyny 10
Amman 9
Atlanta 9
Baghdad 9
Belo Horizonte 9
Catania 9
Chennai 9
City of London 9
Clifton 9
Falls Church 9
Hillsboro 9
Montreal 9
Tashkent 9
Timisoara 9
Can Tho 8
Guangzhou 8
North Bergen 8
Prato 8
Recife 8
Totale 8.945
Nome #
Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study 311
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 271
Low molecular weight heparin does not increase bleeding and mortality post-endoscopic variceal band ligation in cirrhotic patients 234
Adherence to Mediterranean diet in liver transplant recipients: a cross-sectional multicenter study 232
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 228
Altered clot formation and lysis are associated with increased fibrinolytic activity in ascites in patients with advanced cirrhosis 218
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 211
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 206
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 192
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 187
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 184
Assessment of Liver Fibrosis With Elastography Point Quantification vs Other Noninvasive Methods 182
Alcohol use disorder and liver transplant: new perspectives and critical issues 179
Characterization of lymphocyte subsets in ascitic fluid and peripheral blood of decompensated cirrhotic patients with chronic hepatitis C and alcoholic liver disease: A pivotal study 176
End-procedural adherence to recommended hemodynamic targets does not improve the outcome of elective tips in cirrhotic patients 172
Oxidative stress–induced fibrinogen modifications in liver transplant recipients: unraveling a novel potential mechanism for cardiovascular risk 167
Hepatitis C virus recurrence after liver transplantation: A 10-year evaluation 165
Bioelectrical impedance vector analysis and cardiovascular performance in liver-transplanted recipients 164
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 164
Cellular and molecular mechanisms underlying liver fibrosis regression 163
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals. 161
Treatment of nonalcoholic steatohepatitis in adults: Present and future 160
Transjugular intrahepatic Porto-systemic shunt positively influences the composition and metabolic functions of the gut microbiota in cirrhotic patients 160
The changing scenario of hepatocellular carcinoma in Italy: an update 159
La prospettiva psicosomatica nella clinica dei trapianti d'organo. 153
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 151
Super-resolution microscopy reveals an altered fibrin network in cirrhosis: The key role of oxidative stress in fibrinogen structural modifications 150
Pattern of macrovascular invasion in hepatocellular carcinoma 150
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer 149
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 149
Unsupervised Exercise Intervention vs. Adherence to a Mediterranean Diet Alone: The Role of Bioelectrical Impedance Vector Analysis and Cardiovascular Performance in Liver-Transplanted Recipients 146
Needs evaluation questionnaire for liver disease: a novel assessment of unmet needs in patients with chronic liver disease 146
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B. 145
Cryptogenic cholestasis in young and adults: ATP8B1, ABCB11, ABCB4, and TJP2 gene variants analysis by high-throughput sequencing 143
Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view 142
Relevance of Spontaneous Portosystemic Shunts Detected with CT in Patients with Cirrhosis 140
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 140
Non-alcoholic fatty liver disease and metabolic syndrome after liver transplant 136
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 135
Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach 134
Gold standard assays for the monitoring of patients with chronic hepatitis C 134
The MELD score in patients awaiting liver transplant: Strengths and weaknesses 132
Alcohol and viral hepatitis: A mini-review 132
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 130
Nonalcoholic steatohepatitis before and after liver transplant: keeping up with the times 129
Fatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart Study 128
Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems 127
Everolimus Mitigates the Risk of Hepatocellular Carcinoma Recurrence after Liver Transplantation 124
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease 124
A Review on Extrahepatic Manifestations of Chronic Hepatitis C Virus Infection and the Impact of Direct-Acting Antiviral Therapy 124
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease article 124
Surgical site infection prevention and management in immunocompromised patients: a systematic review of the literature 123
Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C 123
Frailty after Liver Transplantation: A Complex Unexplored Issue 122
Aging with a Liver Graft: Analysis of Very Long-Term Survivors after Liver Transplantation 122
Multidisciplinary view of alcohol use disorder: From a psychiatric illness to a major liver disease 122
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 122
Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool 122
The use of obeticholic acid for the management of non-viral liver disease: current clinical practice and future perspectives 122
Statin-induced, immune-mediated injury with simultaneous targeting of skeletal muscle, skin and liver 122
Real-world analysis on the use of gamma-hydroxybutyric acid for alcohol withdrawal syndrome in hospitalized patients with diagnosis of cirrhosis 121
Metabolic Disorders After Liver Transplantation 121
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? 118
Microbiota and viral hepatitis: State of the art of a complex matter 118
Stem cells for end stage liver disease: How far have we got? 117
Biological therapies in patients with liver disease: are they really lifesavers? 116
From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic 115
Non-alcoholic steatohepatitis and liver transplantation 114
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18 114
Metabolic Disorders in Liver Transplant Recipients: The State of the Art 112
Vitamins in the treatment of chronic viral hepatitis 112
Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? 111
Immune Checkpoint Inhibitors in the Pre-Transplant Hepatocellular Carcinoma Setting: A Glimpse Beyond the Liver 109
Acute abdomen in the immunocompromised patient: WSES, SIS-E, WSIS, AAST, and GAIS guidelines 109
Familial intrahepatic cholestasis: New and wide perspectives 107
Hepatitis B virus-related cryogobulinemic vasculitis. The role of antiviral nucleot(s)ide analogues: a review 107
Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients 106
Virological Treatment Monitoring for Chronic Hepatitis B 105
Primary biliary cholangitis associated with SARS-CoV-2 infection 105
Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: Sequence analysis and therapeutic strategy 105
NS5A inhibitors for the treatment of hepatitis C infection 105
Physical activity in liver transplant recipients: a large multicenter study 104
Impact of psychosocial status on liver transplant process 103
Study of the serum metabolomic profile in nonalcoholic fatty liver disease: Research and clinical perspectives 103
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 102
Menopause, and not age, is a critical factor associated with a worse response to antiviral therapy in women affected by chronic hepatitis C 102
Hepatitis C: clinical management and debated issues 102
Peginterferon-A-2B plus ribavirin is more effective than peginterferon-A-2A plus ribavirin in menopausal women with chronic hepatitis C 101
Impact and Novel Perspective of Immune Checkpoint Inhibitors in Patients with Early and Intermediate Stage HCC 100
Worsening of serum lipid profile after direct acting antiviral treatment 99
5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial 96
Liver transplantation for patients with alcoholic liver disease: An open question 96
Hepatitis C Virus-related chronic liver disease in elderly patients: An Italian cross-sectional study 94
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: A single center case-control study 91
Letter: TNFα inhibitors and prevalence of fatty liver disease in chronic inflammatory diseases 91
Influence of age and gender before and after liver transplantation 90
HBV and HCV testing outcomes among marginalized communities in Italy, 2019–2024: a prospective study 88
Liver transplantation and nonalcoholic steatohepatitis: the state of the art 87
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 85
In response 79
Totale 13.623
Categoria #
all - tutte 44.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022441 0 28 58 9 13 5 14 38 40 30 60 146
2022/20231.013 102 287 35 37 25 189 143 48 91 9 30 17
2023/2024515 12 32 89 20 29 53 16 128 15 62 38 21
2024/20253.990 155 398 202 502 1.129 611 187 135 204 100 149 218
2025/20266.394 478 858 722 799 474 246 603 322 388 380 285 839
2026/2027460 306 154 0 0 0 0 0 0 0 0 0 0
Totale 14.186